| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regular Article |
The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia. Twenty-eight elderly patients with dementia and agitated behaviors were randomly assigned to double-blind treatment with either trazodone (50–250 mg/day) or haloperidol (1–5 mg/day) for 9 weeks. There was no significant difference in improvement between the medication groups. Adverse effects, however, were more common in the group treated with haloperidol. Improvement in individual areas suggested that repetitive, verbally aggressive, and oppositional behaviors responded preferentially to trazodone, whereas symptoms of excessive motor activity and unwarranted accusations responded preferentially to haloperidol. These results indicate that moderate doses of trazodone and haloperidol are equally effective for treatment of overall agitated behaviors in patients with dementia, but specific symptoms may respond preferentially to a particular agent.
This article has been cited by other articles:
|
|
 |
|
  J. L. Cummings Neuropsychiatric and behavioral alterations and their management in moderate to severe Alzheimer disease Neurology, September 27, 2005; 65(6_suppl_3): S18 - S24. [Full Text]
|
|
|
|
 |
|
 J. L. Cummings Alzheimer's Disease N. Engl. J. Med., July 1, 2004; 351(1): 56 - 67. [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Ramadan, B. J. Naughton, and R. Prior Correlates of Behavioral Disturbances and Pattern of Psychotropic Medication Use in Five Skilled Nursing Facilities J Geriatr Psychiatry Neurol, March 1, 2003; 16(1): 8 - 14. [Abstract] [PDF]
|
|
|
|
 |
|
 O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, and S. T. DeKosky Patterns of Change in the Treatment of Psychiatric Symptoms in Patients With Probable Alzheimer's Disease From 1983 to 2000 J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Pollock, B. H. Mulsant, J. Rosen, R. A. Sweet, S. Mazumdar, A. Bharucha, R. Marin, N. J. Jacob, K. A. Huber, K. B. Kastango, et al. Comparison of Citalopram, Perphenazine, and Placebo for the Acute Treatment of Psychosis and Behavioral Disturbances in Hospitalized, Demented Patients Am J Psychiatry, March 1, 2002; 159(3): 460 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Sukonick, B. G. Pollock, R. A. Sweet, B. H. Mulsant, J. Rosen, W. E. Klunk, K. B. Kastango, S. T. DeKosky, and R. E. Ferrell The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease Arch Neurol, September 1, 2001; 58(9): 1425 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Lanctôt, N. Herrmann, and P. Mazzotta Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21. [Abstract] [Full Text]
|
|
|
|
|
|
L. Teri, R. G. Logsdon, E. Peskind, M. Raskind, M. F. Weiner, R. E. Tractenberg, N. L. Foster, L. S. Schneider, M. Sano, P. Whitehouse, et al. Treatment of agitation in AD: A randomized, placebo-controlled clinical trial Neurology, November 14, 2000; 55(9): 1271 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Hawkins, J. R. Tinklenberg, J. I. Sheikh, C. E. Peyser, and J. A. Yesavage A Retrospective Chart Review of Gabapentin for the Treatment of Aggressive and Agitated Behavior in Patients With Dementias Am J Geriatr Psychiatry, August 1, 2000; 8(3): 221 - 225. [Abstract] [Full Text]
|
|
|
|
|
|
F. H. Ramadan, B. J. Naughton, and A. G. Bassanelli Treatment of Verbal Agitation with a Selective Serotonin Reuptake Inhibitor J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 56 - 59. [Abstract] [PDF]
|
|
|
|
|
|
H. Lavretsky and D. Sultzer A Structured Trial of Risperidone for the Treatment of Agitation in Dementia Am J Geriatr Psychiatry, May 1, 1998; 6(2): 127 - 135. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |
